Antimicrobial phenotypes and molecular basis in clinical strains of Clostridium difficile
- 1 September 2007
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 59 (1) , 1-5
- https://doi.org/10.1016/j.diagmicrobio.2007.03.009
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Antecedent use of fluoroquinolones is associated with resistance to moxifloxacin in Clostridium difficileClinical Microbiology & Infection, 2003
- Fluoroquinolones: Structure and Target SitesCurrent Drug Targets, 2003
- Prevalence and association of macrolide-lincosamide- streptogramin B (MLSB) resistance with resistance to moxifloxacin in Clostridium difficileJournal of Antimicrobial Chemotherapy, 2003
- The clostridial mobilisable transposonsCellular and Molecular Life Sciences, 2002
- gyrA and gyrB Mutations Are Implicated in Cross-Resistance to Ciprofloxacin and Moxifloxacin in Clostridium difficileAntimicrobial Agents and Chemotherapy, 2002
- Mechanisms of Resistance to Macrolides and Lincosamides: Nature of the Resistance Elements and Their Clinical ImplicationsClinical Infectious Diseases, 2002
- Genomic analysis of the erythromycin resistance element Tn5398 from Clostridium difficile The GenBank accession number for the Tn5398 element and flanking sequence is AF109075.Microbiology, 2001
- Resistance to Moxifloxacin in Toxigenic Clostridium difficile Isolates Is Associated with Mutations in gyrAAntimicrobial Agents and Chemotherapy, 2001
- The Macrolide-Lincosamide-Streptogramin B Resistance Determinant from Clostridium difficile 630 Contains Two erm (B) GenesAntimicrobial Agents and Chemotherapy, 2000
- Epidemics of Diarrhea Caused by a Clindamycin-Resistant Strain ofClostridium difficilein Four HospitalsNew England Journal of Medicine, 1999